DAIC

FEBRUARY 2, 2024

As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. Circulation Research. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

ADN Center of Excellence

SEPTEMBER 2, 2024

Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow. It occurs when the heart's upper chambers (atria) beat out of sync with the lower chambers (ventricles).

AFIB 52

AFIB Atrial Fibrillation Innovation Heart Rhythm 52

DAIC

FEBRUARY 29, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

APRIL 6, 2024

milla1cf Sat, 04/06/2024 - 08:00 April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more than 70 discussions during the American College of Cardiology (ACC) Annual Scientific Session April 6-8 in Atlanta.

Research 105

Research Cardiac Arrest Electrophysiology Chest Pain 105

DAIC

JANUARY 24, 2024

Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. Makkar: Also, patients have earlier access to the most innovative treatments because we are often leading clinical trials and using new devices and novel approaches.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

FEBRUARY 24, 2025

This article will explore how AI-driven diagnostics are reshaping cardiovascular medicine and how can healthcare leaders can leverage these innovations to improve patient care and control costs.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:38 January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD , associate director of the Smidt Heart Institute at Cedars-Sinai , is the recipient of this year’s American College of Cardiology ( ACC ) Distinguished Scientist Award-Clinical Domain. “I Photo by Cedars-Sinai.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

DAIC

MARCH 28, 2024

Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 6 Learn more about Biosense Webster's PFA research and clinical evidence here. Circulation Research.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

DECEMBER 14, 2023

"The PulseSelect PFA system, together with the CE Marked Affera mapping and ablation system and our strong Cryo platform, enables us to provide a broad portfolio of solutions to clinicians and their patients, all developed with years of research and supported by compelling scientific evidence."

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

Cardiomatics

AUGUST 4, 2022

It can help shorten queues to cardiologists, extend prevention and treatment to a wider group of patients, offer precise and early detection of heart rhythm abnormalities, reduce bureaucracy , and increase time for doctor-patient contact. In the long term this increases patient satisfaction with health care services.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Coronary Artery Disease 52

Cardiometabolic Health Congress

JANUARY 2, 2025

Significance: Landiolol offers a new, highly selective beta-1 blocker for managing abnormally fast heart rhythms, addressing an important need in cardiac health management. Heart rate reduction within 10 minutes : Landiolol: 40%-90%. Studies on Supraventricular Tachycardia : 5 studies , a total of 317 adults.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Innovation 52